Find a company
BRCA-DIRECT is an efficient NHS-embedded end-to-end clinical workflow involving a digital platform, saliva-sample postal pathway and genetic counsellor telephone hotline. This means that rather than clinician-intensive hospital appointments to deliver in-person the rather generic pre-test genetic counselling content, patients can receive pre-test information about the test and their test results in their home, by their timing, with their family. A genetic counsellor hotline enables immediate, convenient recourse to expert information, if individualised questions or concerns arise. Implementation of this clinician-light system means more patients with cancer can benefit from genetic testing for high-risk cancer genes like BRCA1 and BRCA2.
| Project | BRCA-DIRECT: A digital pathway for germline genetic testing in women with breast cancer |
|---|---|
| Description |
BRCA-DIRECT is an efficient NHS-embedded end-to-end clinical workflow involving a digital platform, saliva-sample postal pathway and genetic counsellor telephone hotline, the implementation of which means more patients with cancer can benefit from genetic testing for high-risk cancer genes like BRCA1 and BRCA2. |
| Funding | £ 1,902,636 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer |
| Health Innovation Network Partner | UCL Partners |
| Website | https://www.icr.ac.uk/our-research/researchers-and-teams/professor-clare-turnbull |